Cetrotide® (cetrorelix acetate for injection)

Important Safety Information

Cetrotide® is contraindicated in women who are pregnant, are nursing, or have severe renal impairment. Cetrotide® is also contraindicated in women who exhibit or have known hypersensitivity to cetrorelix acetate, mannitol, extrinsic peptide hormone, GnRH or any other GnRH analogs. Treatment with Cetrotide® is not advised in women with severe allergic conditions. Cases of hypersensitivity reactions, including anaphylactoid reactions have been reported. Other adverse events reported include ovarian hyperstimulation syndrome, nausea, headache, and local injection site reactions. Multiple births and congenital abnormalities have been reported.

For complete information, please see full Prescribing information

Cetrotide® is a registered trademark of Merck KGaA, Darmstadt, Germany or its affiliates.

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...